GSK's Position on Pharmacogenetic Testing

Nature Reviews Genetics - United Kingdom
doi 10.1038/nrg909-c2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Impact of Pharmacogenetic Testing on Antidepressant Therapy

Annals of Depression and Anxiety
2017English

Pharmacogenetic Testing Opportunities in Cardiology Based on Exome Sequencing

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2014English

Role of Warfarin Pharmacogenetic Testing in Clinical Practice

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2010English

Letter: California's Position on Pregnancy Testing.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1976English

Pharmacogenetic Testing on Warfarin and Clopidorgel in Conditions of a Multiprofile Hospital

Medical News of North Caucasus
Medicine
2017English

Patient Experiences With Pharmacogenetic Testing in a Primary Care Setting

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

The Landscape of Pharmacogenetic Testing in a US Managed Care Population

Genetics in Medicine
MedicineGenetics
2020English

Genotype and Phenotype Concordance for Pharmacogenetic Tests Through Proficiency Survey Testing: An Update

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2020English

Integrating Force and Position: Testing Model Predictions

Experimental Brain Research
Neuroscience
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy